Abstract
Background and Aims: Menopause may increase cardiovascular disease risk by modulating metabolic pathways affecting circulating metabolome. Previous metabolomics studies on menopause have relied upon self-reported menopausal status determination. We studied menopause-associated metabolite changes in detail by individualising participant follow-up and monitoring their peri- to postmenopause transition with menstrual diaries and hormone measurements.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
